Goldenwell Biotech, Inc. (GWLL)
OTCMKTS · Delayed Price · Currency is USD
0.2000
0.00 (0.00%)
At close: May 16, 2025
Goldenwell Biotech Revenue
Goldenwell Biotech had revenue of $139.00 in the twelve months ending March 31, 2025, down -66.43% year-over-year. In the year 2024, Goldenwell Biotech had annual revenue of $139.00, down -92.43%.
Revenue
139.00
Revenue Growth
-66.43%
P/S Ratio
142,446.04
Revenue / Employee
n/a
Employees
n/a
Market Cap
19.80M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 139.00 | -1.70K | -92.43% |
| Dec 31, 2023 | 1.84K | -45.96K | -96.16% |
| Dec 31, 2022 | 47.80K | 31.83K | 199.37% |
| Dec 31, 2021 | 15.97K | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cordyceps Sunshine Biotech Holdings | 1.25M |
| Cuisine Solutions | 80.48M |
| Armanino Foods of Distinction | 69.40M |
| South Dakota Soybean Processors, LLC | 524.07M |
| Microalliance Group | 22.88M |
| ESG Inc. | 11.89M |
| Pyxus International | 2.48B |
| Crimson Wine Group | 71.52M |